Journal of neuroimmunologyAnimalsEncephalomyelitisAutoimmuneExperimentalDexamethasone
Prior dexamethasone exposure attenuates the therapeutic efficacy of mouse bone marrow-derived mesenchymal stem cells in experimental autoimmune encephalomyelitis by fostering a hostile immunological microenvironment.
Yaling Zhang, Xiaoqiang Lv, Qing Wang, Xuan Ma, Ruotong Wu, Tingting Cui, Xiaoli Ding, Qian Zhang, Luting Yang, Cungen Ma, Yaping Yan
Published: 202610.1016/j.jneuroim.2025.578814
Abstract
Bone marrow-derived mesenchymal stem cells (BMSCs) are promising candidates for treating autoimmune diseases like multiple sclerosis (MS) due to their ability to differentiate into multiple lineages and their immunomodulatory properties. However, the…
Preview only. Read the full abstract at the source